123 related articles for article (PubMed ID: 37793994)
21. Impact of ABCB1, ABCG2, and CYP3A5 polymorphisms on plasma trough concentrations of apixaban in Japanese patients with atrial fibrillation.
Ueshima S; Hira D; Fujii R; Kimura Y; Tomitsuka C; Yamane T; Tabuchi Y; Ozawa T; Itoh H; Horie M; Terada T; Katsura T
Pharmacogenet Genomics; 2017 Sep; 27(9):329-336. PubMed ID: 28678049
[TBL] [Abstract][Full Text] [Related]
22. [Relationship between UGT1A4 142T>G polymorphism and serum concentration of lamotrigine in Chinese epileptic patients: a meta-analysis].
Li Z; Wang Y
Zhonghua Yi Xue Za Zhi; 2018 Nov; 98(41):3365-3370. PubMed ID: 30440130
[No Abstract] [Full Text] [Related]
23. Population pharmacokinetics of lamotrigine co-administered with valproic acid in Chinese epileptic children using nonlinear mixed effects modeling.
Xu S; Liu L; Chen Y; Liu M; Lu T; Wang H; Liu S; Zhao M; Zhao L
Eur J Clin Pharmacol; 2018 May; 74(5):583-591. PubMed ID: 29340733
[TBL] [Abstract][Full Text] [Related]
24. Estrogen profile- and pharmacogenetics-based lamotrigine dosing regimen optimization: Recommendations for pregnant women with epilepsy.
Wang ML; Tao YY; Sun XY; Guo Y; Wang ZY; Cao YF; Zhao L
Pharmacol Res; 2021 Jul; 169():105610. PubMed ID: 33857625
[TBL] [Abstract][Full Text] [Related]
25. Correlation between clinical response to sorafenib in hepatocellular carcinoma treatment and polymorphisms of P-glycoprotein (ABCB1) and of breast cancer resistance protein (ABCG2): monocentric study.
Tandia M; Mhiri A; Paule B; Saffroy R; Cailliez V; Noé G; Farinotti R; Bonhomme-Faivre L
Cancer Chemother Pharmacol; 2017 Apr; 79(4):759-766. PubMed ID: 28289864
[TBL] [Abstract][Full Text] [Related]
26. Effects of the ABCG2 and ABCB1 drug transporter polymorphisms on the pharmacokinetics of bicalutamide in humans.
Kim KA; Cha YJ; Lee HM; Joo HJ; Park JY
Clin Chim Acta; 2015 Jan; 438():7-11. PubMed ID: 25124867
[TBL] [Abstract][Full Text] [Related]
27. UGT2B7_-161C>T polymorphism is associated with lamotrigine concentration-to-dose ratio in a multivariate study.
Blanca Sánchez M; Herranz JL; Leno C; Arteaga R; Oterino A; Valdizán EM; Nicolas JM; Adín J; Shushtarian M; Armijo JA
Ther Drug Monit; 2010 Apr; 32(2):177-84. PubMed ID: 20216122
[TBL] [Abstract][Full Text] [Related]
28. Effects of UGT1A4 genetic polymorphisms on serum lamotrigine concentrations in Chinese children with epilepsy.
Wang Q; Liang M; Dong Y; Yun W; Qiu F; Zhao L; Guo Y
Drug Metab Pharmacokinet; 2015 Jun; 30(3):209-13. PubMed ID: 25922177
[TBL] [Abstract][Full Text] [Related]
29. ABCG2 polymorphisms, 34G>A and 421C>A in a Korean population: analysis and a comprehensive comparison with other populations.
Kim KA; Joo HJ; Park JY
J Clin Pharm Ther; 2010 Dec; 35(6):705-12. PubMed ID: 21054463
[TBL] [Abstract][Full Text] [Related]
30. Impact of genetic variation in breast cancer resistance protein (BCRP/ABCG2) on sunitinib pharmacokinetics.
Mizuno T; Fukudo M; Terada T; Kamba T; Nakamura E; Ogawa O; Inui K; Katsura T
Drug Metab Pharmacokinet; 2012; 27(6):631-9. PubMed ID: 22673043
[TBL] [Abstract][Full Text] [Related]
31. Influence of the UGT2B7 -161C>T polymorphism on the population pharmacokinetics of lamotrigine in Thai patients.
Singkham N; Towanabut S; Lertkachatarn S; Punyawudho B
Eur J Clin Pharmacol; 2013 Jun; 69(6):1285-91. PubMed ID: 23263737
[TBL] [Abstract][Full Text] [Related]
32. Meta-Analysis of ABCG2 and ABCB1 Polymorphisms With Sunitinib-Induced Toxicity and Efficacy in Renal Cell Carcinoma.
Sun F; Chen Z; Yao P; Weng B; Liu Z; Cheng L
Front Pharmacol; 2021; 12():641075. PubMed ID: 33762959
[No Abstract] [Full Text] [Related]
33. Effects of UGT2B7 Genetic Polymorphisms on Serum Concentrations of Valproic Acid in Chinese Children With Epilepsy Comedicated With Lamotrigine.
Wang Q; Zhao L; Liang M; Dong Y; Yun W; Qiu F; Meng H; Guo Y
Ther Drug Monit; 2016 Jun; 38(3):343-9. PubMed ID: 26717295
[TBL] [Abstract][Full Text] [Related]
34. A dosing algorithm for converting from valproate monotherapy to lamotrigine monotherapy in patients with epilepsy.
Sale ME; Natarajan S; Biton V; Vuong A; Hammer AE; Messenheimer JA; Blum D
Epilepsy Behav; 2005 Feb; 6(1):63-70. PubMed ID: 15652736
[TBL] [Abstract][Full Text] [Related]
35. Effects of ABCB1 and ABCG2 polymorphisms on the pharmacokinetics of abemaciclib.
Maeda A; Ando H; Irie K; Hashimoto N; Morishige JI; Fukushima S; Okada A; Ebi H; Matsuzaki M; Iwata H; Sawaki M
Eur J Clin Pharmacol; 2022 Aug; 78(8):1239-1247. PubMed ID: 35527301
[TBL] [Abstract][Full Text] [Related]
36. Ethosuximide, sodium valproate or lamotrigine for absence seizures in children and adolescents.
Brigo F; Igwe SC; Lattanzi S
Cochrane Database Syst Rev; 2021 Jan; 1(1):CD003032. PubMed ID: 33475151
[TBL] [Abstract][Full Text] [Related]
37. Different effects of the ABCG2 c.421C>A SNP on the pharmacokinetics of fluvastatin, pravastatin and simvastatin.
Keskitalo JE; Pasanen MK; Neuvonen PJ; Niemi M
Pharmacogenomics; 2009 Oct; 10(10):1617-24. PubMed ID: 19842935
[TBL] [Abstract][Full Text] [Related]
38. Ethosuximide, sodium valproate or lamotrigine for absence seizures in children and adolescents.
Brigo F; Igwe SC; Lattanzi S
Cochrane Database Syst Rev; 2019 Feb; 2(2):CD003032. PubMed ID: 30734919
[TBL] [Abstract][Full Text] [Related]
39. Factors that influence the pharmacokinetics of lamotrigine in Japanese patients with epilepsy.
Inoue K; Yamamoto Y; Suzuki E; Takahashi T; Umemura A; Takahashi Y; Imai K; Inoue Y; Hirai K; Tsuji D; Itoh K
Eur J Clin Pharmacol; 2016 May; 72(5):555-62. PubMed ID: 26790665
[TBL] [Abstract][Full Text] [Related]
40. Association between lamotrigine concentrations and ABCB1 polymorphisms in patients with epilepsy.
Lovrić M; Božina N; Hajnšek S; Kuzman MR; Sporiš D; Lalić Z; Božina T; Granić P
Ther Drug Monit; 2012 Oct; 34(5):518-25. PubMed ID: 22972536
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
